Active immunotherapy options for Alzheimer’s disease

Alzheimer’s disease (AD) is the most common cause of dementia and a major contributor to disability and dependency among older people. AD pathogenesis is associated with the accumulation of amyloid-beta protein (Aβ) and/or hyperphosphorylated tau protein in the brain. At present, current therapies p...

Descripción completa

Detalles Bibliográficos
Autores principales: Winblad, Bengt, Graf, Ana, Riviere, Marie-Emmanuelle, Andreasen, Niels, Ryan, J Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979042/
https://www.ncbi.nlm.nih.gov/pubmed/24476230
http://dx.doi.org/10.1186/alzrt237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979042/
https://www.ncbi.nlm.nih.gov/pubmed/24476230
http://dx.doi.org/10.1186/alzrt237

Ejemplares similares